TJS Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Lixil Corp

Watchlist Manager

Watchlist

Price: 9.3 EUR -0.53%

Market Cap: €2.7B

L	Lixil Corp F:TJS	JP
B	Brembo SpA F:BRCA	IT
P	Prudential PLC XMUN:PRU	UK
T	Timah Tbk PT F:TIH1	ID
	Tejon Ranch Co NYSE:TRC	US
	Nedap NV F:NE3	NL
S	Siemens AG SWB:SIE	DE
	Fuchs Se F:FPE3	DE
E	Endo International PLC F:EO7	IE
M	Mitsubishi Heavy Industries Ltd XMUN:MIH	JP
I	Integra Lifesciences Holdings Corp F:IL3	US
	HAL Trust AEX:HAL	MC
J	Johnson Matthey PLC SWB:JMT2	UK
	Soleno Therapeutics Inc F:6XC	US

Profitability Summary

Lixil Corp's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Healthy Gross Margin

34%

Sustainable 3Y Average Gross Margin

33%

Gross Margin is Increasing

31% > 34%

Low Operating Margin

Low 3Y Average Operating Margin

Operating Margin is Increasing

1% > 2%

Low Net Margin

Negative 3Y Average Net Margin

Declining Net Margin

1% > 0%

Healthy Free Cash Flow Margin

Sustainable 3Y Average Free Cash Flow Margin

Free Cash Flow Margin is Increasing

-3% > 2%

Low ROE

Negative 3Y Average ROE

Declining ROE

2% > 1%

Low ROIC

Negative 3Y Average ROIC

Declining ROIC